What changed?

GHK-Cu Research & Clinical Development Updates

A sourced timeline of research records and material development changes tracked by BACToBasics for GHK-Cu. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.

Tracked items

3

Research sources

2

Development entries

1

Latest recorded date

Verified 2026-09-05

Latest development activity

Small randomized topical study after CO2 laser resurfacing.

Verified 2026-09-05 · Early human evidence — topical route · No established development program

GHK-Cu has small human studies in topical/cosmetic contexts, but that route-limited evidence does not establish an injectable clinical-development program.

Open source ↗

Latest research record by publication date

FDA Safety-Risk Listing — Injectable GHK-Cu

Published 2026 · Regulatory · Regulatory / safety review

FDA specifically distinguishes injectable GHK-Cu from topical use and notes limited human safety data for injectable routes.

Open source ↗

Tracked timeline

Research and development record

Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.

Development snapshotVerified 2026-09-05

Small randomized topical study after CO2 laser resurfacing.

Early human evidence — topical route · No established development program

GHK-Cu has small human studies in topical/cosmetic contexts, but that route-limited evidence does not establish an injectable clinical-development program.

Follow future GHK-Cu changes

Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.

Browse all compound updates →Research Library →Clinical Development →

BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.